Anne Peters, MD, an endocrinologist with Keck Medicine, has been working with these types of drugs for 20 years
Inadequate carnitine availability can precipitate significant metabolic disturbances and associated pathological conditions
It is intended for research and laboratory use only, commonly utilized for the reconstitution of lyophilized peptides and other non-clinical compounds under controlled conditions
In our future work, we will examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions. The findings were published in the journal Diabetes, Obesity and Metabolism.
Please include your phone number and email, as we are unable to respond directly to messages sent without contact info